Glee Pharma Private Limited
About Glee Pharma Private Limited
Data last updated:
Glee Pharma Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 22 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U51397OR2011PTC013348. Its GSTIN is 21AAECG1897J1ZI (Odisha).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandi Prasad Das and Sasmita Mohanty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at At – Plot No – 5D – 879 Sector – 9 Cda, Cuttack, Odisha, India – 753014.
As per the financials filed for FY 2025, the company reported a revenue of ₹90.73 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹80,279 (net margin 0.9%) and EBITDA of ₹12.4 Lakh (EBITDA margin 13.7%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 10% over five years.
The company has about 5 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressAt – Plot No – 5D – 879 Sector – 9 Cda, Cuttack, Odisha, India – 753014
- IndustryTrading, Other Wholesale, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Glee Pharma Private Limited
The main business activity of Glee Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Glee Pharma Private Limited FY 2025 filings available
Glee Pharma Private Limited reported revenue of ₹90.73 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Glee Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 6% fall in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Glee Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.4 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹80,279 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Glee Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Glee Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Glee Pharma Private Limited
Glee Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eranik Naturals Private Limited | ₹90.79 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Pune, Maharashtra, India |
| Unipower Pharmaceuticals Private Limited | ₹90.78 Lakh (FY 2025) | •••• | •••• | -24.0% | •••• | Delhi, India |
| Global Haida Trading Private Limited | ₹90.76 Lakh (FY 2025) | •••• | •••• | 51.0% | •••• | Tirupur, Tamil Nadu, India |
| SJ Diginet Private Limited | ₹90.74 Lakh (FY 2018) | •••• | •••• | 169.0% | •••• | Dadri, Uttar Pradesh, India |
| Ananya Tradecom Private Limited | ₹90.74 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | Ahmedabad, Gujarat, India |
| Glee Pharma Private Limited this company | ₹90.73 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Cuttack, Odisha, India |
| Ramgarh Krishi Producer Company Limited | ₹90.73 Lakh (FY 2025) | •••• | •••• | 61.0% | •••• | Jamwaramgarh, Rajasthan, India |
| Franco Exports Private Limited | ₹90.73 Lakh (FY 2024) | •••• | •••• | -2.0% | •••• | Tamil Nadu, India |
| Mohit Dealers Private Limited | ₹90.73 Lakh (FY 2024) | •••• | •••• | 36.0% | •••• | Kolkata, West Bengal, India |
| Chillz Engineering Private Limited | ₹90.72 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Chennai, Tamil Nadu, India |
| Futurez India Private Limited | ₹90.72 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Glee Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Glee Pharma Private Limited
Glee Pharma Private Limited is audited by PRATAP AND CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PRATAP AND CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Glee Pharma Private Limited
Glee Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandi Prasad Das | Director | 22 Mar 2011 | 15 Years 6 Months | Current |
| Sasmita Mohanty | Director | 05 Dec 2011 | 14 Years 10 Months | Current |
Ownership and Shareholding of Glee Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Glee Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2024 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Glee Pharma Private Limited
Glee Pharma Private Limited has 1 court case on record: 1 filed by Glee Pharma. All case is disposed. Status as checked on 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Orissa | Writ petition | Filed by the company against Central Board of Indirect Taxes | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Glee Pharma Private Limited
Glee Pharma Private Limited has a workforce of 5 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Glee Pharma Private Limited
Glee Pharma Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Pranaya Ranjan Mohanty ceased to be Managing Director on 19 Jun 2017.
Credit Ratings, Litigation & Regulatory Alerts for Glee Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Glee Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Glee Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Glee Pharma Private Limited
Glee Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AAECG1897J1ZI | Odisha | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Glee Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glee Pharma Private Limited
Glee Pharma is an active private limited company based in Cuttack, Odisha, India. The company works in other wholesale, within the trading industry. It was incorporated on 22 March 2011 (15+ years old) and is registered under CIN U51397OR2011PTC013348.
Glee Pharma reported revenue of ₹90.73 Lakh for FY 2025 (down 6% YoY).
Glee Pharma has 2 current directors:
- Chandi Prasad Das - Director
- Sasmita Mohanty - Director
Glee Pharma reported a net profit of ₹80,279 (net margin 0.9%) and EBITDA of ₹12.4 Lakh (EBITDA margin 13.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Glee Pharma is 3% over three years and -10% over five years. In the latest year (FY 2025) revenue fell 6%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Glee Pharma is 21AAECG1897J1ZI, registered in Odisha.
The CIN (Corporate Identification Number) of Glee Pharma is U51397OR2011PTC013348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glee Pharma has 1 court case on record: 1 filed by the company.
Glee Pharma was incorporated on 22 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Glee Pharma by revenue are Eranik Naturals Private Limited, Unipower Pharmaceuticals Private Limited, Global Haida Trading Private Limited, SJ Diginet Private Limited, Ananya Tradecom Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Pranaya Ranjan Mohanty ceased to be Managing Director on 19 Jun 2017. Sasmita Mohanty was appointed as Director on 05 Dec 2011. Chandi Prasad Das was appointed as Director on 22 Mar 2011.